Sequential Treatment with an Immune Checkpoint Inhibitor Followed by a Small-Molecule Targeted Agent Increases Drug-Induced Pneumonitis

PURPOSE: Immune checkpoint inhibitors (ICI) and targeted small-molecule drugs are mainstay elements of lung cancer chemotherapy. However, they are associated with development of pneumonitis, a rare, but potentially life-threatening event. We analyzed lung cancer patients treated with ICI to evaluate...

Descripción completa

Detalles Bibliográficos
Autores principales: Jung, Jongheon, Kim, Hyae Young, Kim, Dong-Gil, Park, Seog Yun, Ko, A Ra, Han, Ji-Youn, Kim, Heung Tae, Lee, Jin Soo, Lee, Youngjoo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Cancer Association 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7812016/
https://www.ncbi.nlm.nih.gov/pubmed/32777877
http://dx.doi.org/10.4143/crt.2020.543

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7812016/
https://www.ncbi.nlm.nih.gov/pubmed/32777877
http://dx.doi.org/10.4143/crt.2020.543

Ejemplares similares